Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger P.;Michallet M.;Bosman P.;Dietrich S.;Sobh M.;Boumendil A.;Nagler A.;Scheid C.;Cornelissen J.;Niederwieser D.;Muller L.;Vandenberghe E.;Scortechini I.;Schoemans H.;Andersen N. S.;Finke J.;Russo D.

Writing – Original Draft Preparation

;Ljungman P.;Passweg J.;van Gelder M.;Durakovic N.;Labussiere-Wallet H.;Berg T.;Wulf G.;Bethge W.;Bunjes D.;Stilgenbauer S.;Canepari M. E.;Schaap M.;Fox C. P.;Kroger N.;Montoto S.;Schetelig J.

2019-01-01